Cidara Therapeutics expands partnership with WuXi XDC

Cidara Therapeutics has announced the expansion of its existing collaboration with WuXi XDC for advancing the CD73 oncology DFC programme. The deal builds on the existing partnership with WuXi XDC for chemistry, manufacturing, and controls (CMC) development and GMP...

US FDA approves GSK’s Jesduvroq to treat anaemia of CKD

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months. Jesduvroq is an oral hypoxia-inducible factor...